Hypertriglyceridemia: all 302 studies

Page 2 of 4. Open to participants first (38), then studies with results posted, then the rest; newest registration first within each.

• Comparing Tricor, Avandia, or Weight Loss to Lower Cardiovascular Risk Factors in People With High Triglycerides.CompletedNCT00186537Not applicableResults posted
• RBD5044 in Chinese Participants With HypertriglyceridemiaActive, not recruitingNCT07587788Phase 2
• Limosilactobacillus Fermentum CRL 1446 - CONICET CASASCOActive, not recruitingNCT07530575Not applicable
• WB-EMS Effects on Cardiometabolic Risk FactorsActive, not recruitingNCT07406191Not applicable
• Rosemary Infusion for Hypertension With HypertriglyceridemiaCompletedNCT07352124Not applicable
• A Study of SHR-1918 In Participants With HypertriglyceridemiaActive, not recruitingNCT07349615Phase 3
• Comparison of Cardiometabolic Markers in Individuals With Hypertriglyceridemia With Low and High Weight Loss Responses to an Energy-restricted DietCompletedNCT07012226Not applicable
• Cardiometabolic Properties of Omega-3 Functionalized With HydroxytyrosolActive, not recruitingNCT06992323Not applicable
• Long-Term Safety and Efficacy of Plozasiran in Adults With HypertriglyceridemiaActive, not recruitingNCT06822790Phase 3
• Single-ascending Dose Study of Kylo-12 in Healthy SubjectsActive, not recruitingNCT06783881Phase 1
• Evaluation of the Efficacy of Phospholipid-Bound Omega-3 Versus Omega-3 Alone in Patients With Hypertriglyceridemia: A Randomized Clinical TrialActive, not recruitingNCT06749028Not applicable
• A Phase II Study to Evaluate the Efficacy and Safety of of DR10624 in Subjects With Severe HypertriglyceridemiaCompletedNCT06555640Phase 2
• A Study of the Safety of Mibavademab in Pediatric and Adult Participants Switching From Metreleptin to Mibavademab for the Treatment of Generalized Lipodystrophy (GLD)CompletedNCT06548100Phase 3
• Response to an Intervention With Omega-3 (RIO - Study)CompletedNCT06538324Not applicable
• Compassionate Use of EvinacumabApproved for marketingNCT06500598
• Barberry and Cardiometabolic Risk Factors in Individuals With HypertriglyceridemiaCompletedNCT06483932Not applicable
• Study of RN0361in Adult Healthy Subjects and Adult Hypertriglyceridemic SubjectsActive, not recruitingNCT06471543Phase 1/2
• Phase 3 Study of Plozasiran in Adults With HypertriglyceridemiaCompletedNCT06347133Phase 3
• Study of Plozasiran in Adults With Severe HypertriglyceridemiaCompletedNCT06347016Phase 3
• Study of Plozasiran (ARO-APOC3) in Adults With Severe HypertriglyceridemiaCompletedNCT06347003Phase 3
• Stockholm hyperTRIglyceridemia REGister (STRIREG) StudyActive, not recruitingNCT06104943
• Chia Seeds Consumption in HypertriglyceridemiaCompletedNCT06020950Not applicable
• Effects of DHA-NAT on Postprandial Lipidaemia in Healthy Male SubjectsCompletedNCT05953064Not applicable
• Study of MAR001 in Adults With Metabolic DysfunctionCompletedNCT05896254Phase 1/2
• Study of the Efficacy and Safety of NST-1024 Versus Placebo in Subjects With HypertriglyceridemiaCompletedNCT05889156Phase 2
• To Evaluate the Efficacy and Safety of Pegozafermin in Subjects With Severe HypertriglyceridemiaCompletedNCT05852431Phase 3
• A VSA003 Phase 1 Study in Chinese Adult Healthy VolunteersCompletedNCT05851066Phase 1
• Adiponectin, ICAM-1, VCAM-1 Levels and Metabolic Syndrome in Obese AdolescentsCompletedNCT05685017
• CORE-OLE: A Study of Olezarsen (ISIS 678354) Administered Subcutaneously to Participants With Severe Hypertriglyceridemia (SHTG)Active, not recruitingNCT05681351Phase 3
• A Study of Olezarsen (ISIS 678354) in Participants With Hypertriglyceridemia and Atherosclerotic Cardiovascular Disease, or With Severe HypertriglyceridemiaCompletedNCT05610280Phase 3
• A Study of LY3875383 in Healthy Participants and Participants With HypertriglyceridemiaTerminatedNCT05609825Phase 1
• A Study of Olezarsen Administered Subcutaneously to Participants With Severe HypertriglyceridemiaCompletedNCT05552326Phase 3
• Insulin and Standard Management in Hypertriglyceridemic Acute PancreatitisStatus unknownNCT05487833Phase 4
• MN-001 in Non-alcoholic Fatty Liver Disease, Type 2 Diabetes Mellitus, and HypertriglyceridemiaActive, not recruitingNCT05464784Phase 2
• Sustainable-psycho-nutritional Intervention Program and Its Effects on Health Outcomes and the EnvironmentActive, not recruitingNCT05457439Not applicable
• Effect of Candida Rugosa Lipase on Serum Triglyceride LoweringCompletedNCT05295134Not applicable
• Impact of Aronia Berry Consumption on Inflammation, Metabolites, and the Gut MicrobiomeCompletedNCT05255718Not applicable
• Impact of Plasma Lipids on β Cell Function and Insulin SensitivityCompletedNCT05181514Not applicable
• Hypertriglyceridemia Associated Acute Pancreatitis in Intensive Care Unit and Therapeutic PlasmapheresisCompletedNCT05096455
• A Study of Olezarsen (ISIS 678354) Administered to Participants With Severe HypertriglyceridemiaCompletedNCT05079919Phase 3
• Effect of Silibinin(A) as a Potential Anti-obesity AgentActive, not recruitingNCT05069298Not applicable
• Omega-3 Fatty Acid Dietary Intervention (O3DI)CompletedNCT05025943Not applicable
• A Trial to Assess Full-fat or Low-fat Dairy Foods on Insulin Sensitivity, RBC FA's and Other Markers of Metabolic HealthCompletedNCT04999462Not applicable
• Effects of Replacing Energy From Solid Fats and Added Sugars (SoFAS) With AvocadoCompletedNCT04990817Not applicable
• Impact of Beans and Oats Snack Bar on Hypertriglyceridemic WomenCompletedNCT04966494Not applicable
• Study of Cortisol Metabolism in Familial Partial Lipodystrophy Type 2CompletedNCT04845165
• An Efficacy and Safety Study of Omega-3-acid Ethyl Ester in Chinese Subjects With Hypertriglyceridemia.CompletedNCT04756180Phase 3
• A Study to Evaluate the Effect of GFA-918 on Serum Triglyceride Levels in Individuals With Elevated Serum TriglycerideCompletedNCT04754373Phase 2
• Hypertriglyceridemia-associated Acute Pancreatitis: Apheresis Vs. Conservative TreatmentCompletedNCT04708925
• Safety and Efficacy of MAT9001(Omega-3-pentaenoic Acid) in Subjects With Triglycerides ≥500 mg/dL and <2000 mg/dLWithdrawnNCT04662528Phase 3
• Study to Assess Tricor Therapy Effectiveness in Patients With Metabolic Syndrome (TRISTAN)CompletedNCT04650152
• A Phase 1, First Time in Humans Study of NST-1024CompletedNCT04630366Phase 1
• Effects of MET-3 and MET-5 on Gut Microbiome and Metabolic Function in Men and Women With HypertriglyceridemiaStatus unknownNCT04507971Phase 1
• Investigation Of Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of Single Doses Of Vupanorsen In Japanese Healthy Adult Participants With Elevated TriglyceridesCompletedNCT04459767Phase 1
• A First in Human Study of STT-5058, an Antibody That Binds ApoC3TerminatedNCT04419688Phase 1
• The Effect of Lifestyle Intervention for Hypertriglyceridemia on the Pathogenesis of Adverse Pregnancy OutcomeStatus unknownNCT04275622Not applicable
• Interrupting Prolonged Sitting With Periodic Interval Exercise: Effect on Postprandial LipemiaStatus unknownNCT04241081Not applicable
• Efficacy of Ethyl Icosapentate in Patients With Severe HypertriglyceridemiaCompletedNCT04239950Phase 3
• Nutritional Transitions to More Plant Proteins and Less Animal Proteins: Understanding the Induced Metabolic Reorientations and Searching for Their Biomarkers (ProVegOmics)CompletedNCT04236518Not applicable
• InFocus France Epidemiological Study of Health Burden in Major HypertriglyceridemiaCompletedNCT04223908
• Long-term Safety and Efficacy Study of MND-2119 in Patients With HypertriglyceridemiaCompletedNCT04221217Phase 3
• Intermittent Fasting in Hypertriglyceridemic Overweight or Obese SubjectsCompletedNCT04143971Not applicable
• Impacts of Aronia on Inflammation and the Gut MicrobiomeCompletedNCT04128839Not applicable
• Characterization of Fatty Acid Composition of Triglycerides in Patients With Hypertriglyceridemia-induced Acute PancreatitisStatus unknownNCT04097990Not applicable
• Effects of Omega-3 Docosapentaenoic Acid on Lipids and Other Risk Factors for Cardiovascular DiseaseTerminatedNCT04088240Not applicable
• Culturally-Adapted Diet for Puerto Rican AdultsCompletedNCT03975556Not applicable
• Translation of Pritikin Program to the CommunityCompletedNCT03929198Not applicable
• Dark Chocolate, Cholesterol and MicrobiotaStatus unknownNCT03850405Not applicable
• Postprandial Lipid Metabolism in Patients With Hypertriglyceridemia and Normo-lipidemic Controls: Medium Chain Fatty Acids (MCT) in Comparison to Long-chain, Saturated Fatty Acids (SFA) and Mono-unsaturated Fatty Acids (MUFA)CompletedNCT03846908Not applicable
• Study of ARO-APOC3 in Healthy Volunteers, Hypertriglyceridemic Patients and Patients With Familial Chylomicronemia Syndrome (FCS)CompletedNCT03783377Phase 1
• Study of ARO-ANG3 in Healthy Volunteers and in Dyslipidemic PatientsCompletedNCT03747224Phase 1
• Efficacy of MND-2119 in Participants With HypertriglyceridemiaCompletedNCT03693131Phase 3
• PC-300 Tea Effect on Triglyceride LevelsCompletedNCT03649269Not applicable
• Lipid-lowering Effects of Gefarnate in Statin-treated Coronary Heart Disease Patients With Residual HypertriglyceridemiaStatus unknownNCT03610321Phase 2/3
• Effects of Diet Interventions on Monocytes in Metabolic SyndromeCompletedNCT03591588Not applicable
• Efficacy and Safety of Cipros 10 Association on the Isolated Hypertriglyceridemia and Dyslipidemia TreatmentCompletedNCT03527069Phase 3
• Intensive Insulin for Severe/Moderate Hypertriglyceridemia Pancreatitis.Status unknownNCT03501680Phase 4
• Phase I Drug-drug Interaction of Omega-3 and AtorvastatinStatus unknownNCT03438955Phase 1
• A Phase 3 STudy of CaPRe In LOwering Very hiGh TriglYcerides (TRILOGY 1)CompletedNCT03398005Phase 3
• A Phase 3 STudy of CaPRe in LOwering Very hiGh TriglYcerides (TRILOGY 2)CompletedNCT03361501Phase 3
• Intravenous Administration of Insulin and Plasma Exchange on Triglyceride Levels in Early Stage of Hypertriglyceridemia-induced PancreatitisStatus unknownNCT03342807Phase 4
• Setmelanotide in a Single Patient With Partial LipodystrophyCompletedNCT03262610Phase 2
• The Effect of Omega-3 FA on Hypertriglyceridemia in Patients With T2DM(OCEAN)CompletedNCT03120299Phase 4
• Effects of Two Herbal Dietary Supplements on Lipid Metabolism in Moderate Hypercholesterolemia and HypertriglyceridemiaCompletedNCT02989753Phase 1/2
• Metabolic Effects of Egg Protein and Unsaturated Fat Intakes in Subjects With HypertriglyceridemiaCompletedNCT02924558Not applicable
• Safety, Tolerability, PK, and Pharmacodynamics(PD) of IONIS APOCIII-LRx in Healthy Volunteers With Elevated TriglyceridesCompletedNCT02900027Phase 1
• Intestines and Liver Contribution to Fasting Postprandial HypertriglyceridemiaCompletedNCT02898142Not applicable
• Effects of Fluid Milk in Attenuating Hyperglycemia and Hypertriglyceridemia After MealCompletedNCT02894112Not applicable
• Effect of Totum-63, Active Ingredient of Valedia, on Glucose and Lipid Homeostasis on Subjects With PrediabetesCompletedNCT02868177Phase 2/3
• Study to Evaluate the 2-Way Interaction Between Multiple Doses of Epanova™ and a Single Dose of Rosuvastatin (Crestor®)CompletedNCT02859129Phase 1
• Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IONIS ANGPTL3-LRx in Healthy Volunteers With Elevated Triglycerides and Participants With Familial HypercholesterolemiaCompletedNCT02709850Phase 1
• Omega-3-Acid Ethyl Esters 90 Soft Capsules for Lowering Very High TriglyceridesStatus unknownNCT02625870Phase 3
• Efficacy and Safety of Gemcabene in Patients With Low HDL-C and Either Normal or Elevated TriglyceridesCompletedNCT02585869Phase 2
• Effect of Therapeutic Phlebotomies on the Triglycerides Concentration in Patients With Hypertriglyceridemia and HyperferritinemiaCompletedNCT02526121Not applicable
• Maternal Hypertriglyceridaemia StudyStatus unknownNCT02479113
• Understanding Liver Fat Metabolism: Studies to Understand the Role of Dietary Sugars on Liver Fat MetabolismCompletedNCT02478541Not applicable
• Genes Involved in Lipid DisordersCompletedNCT02311335
• A PK and PD Study of Two Formulations of Omega-3 One Gram CapsulesCompletedNCT02310022Phase 1/2
• Efficacy and Safety of Prescription Omega-3 Fatty Acid Added to Stable Statin Therapy in Patients With Type 2 Diabetes and HypertriglyceridemiaCompletedNCT02305355Phase 4
• Compassionate Use of Metreleptin in Previously Treated People With Generalized LipodystrophyActive, not recruitingNCT02262832Phase 3

← Hypertriglyceridemia overview